 OncLive | Emerging Treatment Options in Neuroendocrine Tumors OncLive Patients with lung disease, COPD, or uncontrolled diabetes should not receive everolimus. Additionally, Yao notes, someone with cardiovascular disease or hypertension should not receive the VEGF inhibitor sunitinib. Outside of this approach for ... |
